Story perspectives

MIT and Novo Nordisk Unveil Breakthrough in Liver Disease Research

10/3/2025

Summary

Story summary

Massachusetts Institute of Technology (MIT) and Novo Nordisk developed advanced microphysiological systems (MPS) to study liver diseases.
The MPS reproduce human liver conditions for understanding metabolic disorders and testing therapies.
High insulin induces insulin resistance in liver microtissues within a week, worsened by glucose and fatty acids.
Removing metabolic stressors suggests potential reversal of adverse effects and mirrors lifestyle improvements.

1 of 1

Story summary

Massachusetts Institute of Technology (MIT) and Novo Nordisk developed advanced microphysiological systems (MPS) to study liver diseases.
The MPS reproduce human liver conditions for understanding metabolic disorders and testing therapies.
High insulin induces insulin resistance in liver microtissues within a week, worsened by glucose and fatty acids.
Removing metabolic stressors suggests potential reversal of adverse effects and mirrors lifestyle improvements.